	Capitaux D'Emprunt		Date
AbbVie	USD 62.97B	12M	2025-09
Acadia Pharmaceuticals	USD 0	0	2025-03
Agios Pharmaceuticals	USD 1.06M	0	2022-09
Alnylam Pharmaceuticals	USD 1.04B	13.75M	2025-09
Amgen	USD 52.43B	1.33B	2025-09
Arrowhead Research	USD 538.1M	323.22M	2025-12
Biogen	USD 6.29B	1.4M	2025-09
BioMarin Pharmaceutical	USD 596.66M	501K	2025-09
Bristol-Myers Squibb	USD 42.85B	1.62B	2025-12
Gilead Sciences	USD 22.14B	5M	2025-09
Incyte	USD 35.37M	3.61M	2025-09
Insmed	USD 539.72M	21.23M	2025-09
Ionis Pharmaceuticals	USD 28.78M	596.71M	2025-09
J&J	USD 39.41B	173M	2025-09
Merck	USD 39.97B	6B	2025-09
Moderna	USD 26M	6M	2025-09
Neurocrine Biosciences	USD 169.5M	500K	2023-03
Novartis	USD 24.24B	174M	2025-09
Pfizer	USD 57.41B	93M	2025-09
PTC Therapeutics	USD 1.84B	298.68M	2025-09
Regeneron Pharmaceuticals	USD 2.71B	720.4M	2025-12
Roche Holding	CHF 27.43B	966M	2025-12
Sanofi	EUR 15.72B	2.45B	2025-12
Sarepta Therapeutics	USD 1.04B	104.31M	2025-09
Ultragenyx Pharmaceutical	USD 782.75M	11.3M	2025-06
United Therapeutics	USD 100M	100M	2024-06
Vertex Pharmaceuticals	USD 111.4M	1.4M	2025-03

Vertex Pharmaceuticals Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.